The Lumenis Stellar M22 system has connection capability with the following available treatment modules, for multi-application treatment options. All modules are designed for aesthetic and dermatological skin procedure application, as follows:
● IPL with a spectrum of 400-1200nm (with different filters) is indicated for:
o Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles).
o Cutaneous lesions, including warts, scars and striae.
o Benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations.
o Removal of unwanted hair from all skin types, and to effect stable long term, or permanent hair reduction in skin types I-V through selective targeting of melanin in hair follicles.
o Mild to moderate inflammatory Acne (Acne Vulgaris).
● Multi-Spot Nd:YAG Laser, with a wavelength of 1064 nm is indicated for:
o The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1 - 4.0 mm diameter) of the leg.
o The non-ablative treatment of facial wrinkles.
o The removal of unwanted hair from all skin types, and to effect stable long term, or permanent hair reduction in skin types I-V through selective targeting of melanin in hair follicles.
● The 1565nm ResurFX module, with a wavelength of 1565 nm, is indicated for:
o Use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue.
● Q-Switched Nd:YAG Laser, with a wavelength of 1064 nm, is indicated for:
o Treatment of pigmented lesions.
o Removal of dark tattoos.
(*) Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regimen.